Ceftobiprole
You don't need to be Editor-In-Chief to add or edit content to WikiDoc. You can begin to add to or edit text on this WikiDoc page by clicking on the edit button at the top of this page. Next enter or edit the information that you would like to appear here. Once you are done editing, scroll down and click the Save page button at the bottom of the page.
| Ceftobiprole | |
|---|---|
| Image:Ceftobiprole structure.png | |
| IUPAC name | (6R,7R)-7-[ [(2Z)-2-(5-amino-1,2,4-thiadiazol-3-ylidene)-2-nitroso-1-oxoethyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)-3-pyrrolidinyl]-3-pyrrolidinylidene]methyl]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
| Other names | BAL5788 |
| Identifiers | |
| CAS number | |
| PubChem | |
| SMILES | C1CNCC1N2CCC(=CC3=C(N4C(C(C4=O)NC(=O)C(=C5NSC(=N5)N)N=O)SC3)C(=O)O)C2=O |
| Properties | |
| Molecular formula | C20H22N8O6S2 |
| Molar mass | 534.56868 |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references | |
|
WikiDoc Resources for Ceftobiprole | |
|
Articles | |
|---|---|
|
Most recent articles on Ceftobiprole Most cited articles on Ceftobiprole | |
|
Media | |
|
Powerpoint slides on Ceftobiprole | |
|
Evidence Based Medicine | |
|
Clinical Trials | |
|
Ongoing Trials on Ceftobiprole at Clinical Trials.gov Clinical Trials on Ceftobiprole at Google
| |
|
Guidelines / Policies / Govt | |
|
US National Guidelines Clearinghouse on Ceftobiprole
| |
|
Books | |
|
News | |
|
Commentary | |
|
Definitions | |
|
Patient Resources / Community | |
|
Patient resources on Ceftobiprole Discussion groups on Ceftobiprole Patient Handouts on Ceftobiprole Directions to Hospitals Treating Ceftobiprole Risk calculators and risk factors for Ceftobiprole
| |
|
Healthcare Provider Resources | |
|
Causes & Risk Factors for Ceftobiprole | |
|
Continuing Medical Education (CME) | |
|
International | |
|
| |
|
Businness | |
|
Experimental / Informatics | |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Ceftobiprole is an experimental cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus.[1] It was discovered by Basilea Pharmaceutica and is being developed by Johnson & Johnson Pharmaceutical Research and Development.[1]
References
Acknowledgement and Attribution Regarding Sources of Content
Some of the initial content on this page may be incorporated in part from copyleft sources in the public domain including wikis such as Wikipedia and AskDrWiki. Drug information for patients came from the The National Library of Medicine. Infectious disease information may have come from the Centers for Disease Control (CDC). Differential Diagnoses are drawn from clinicians as well as an amalgamation of 3 sources: 1.The Disease Database; 2. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:3; 3. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:7 .
